Hester Biosciences has received the WHO GMP Certification for poultry vaccines. This certification would help the company in hastening the registration process in many countries, as well as in opening the registration doors in the regulated markets.
Besides, the company is also in the process of launching its locally produced Bivalent Marek’s Disease Live vaccine containing HVT & SB1 strains. Currently, trails are being conducted. The market for this vaccine is approximately Rs 30 crore.
At present, nearly 50% of the vaccine requirement is imported. Hester’s local production of this vaccine will be an import replacement, besides providing a cost advantage to the Indian poultry farmers. Hester expects an overall growth of 25% in sales in this financial year, over last year.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1847.30 |
| Dr. Reddys Lab | 1293.25 |
| Cipla | 1347.70 |
| Zydus Lifesciences | 938.90 |
| Lupin | 2377.90 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: